TSPAN2 Antibody (822509) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # FAB7876D
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG2B Clone # 822509
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human TSPAN2
Met1-Ile221
Accession # O60636
Met1-Ile221
Accession # O60636
Specificity
Detects human TSPAN2 in ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for TSPAN2 Antibody (822509) [DyLight 350]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: TSPAN2
Long Name
Tetraspanin 2
Alternate Names
NET3, TSN2
Gene Symbol
TSPAN2
Additional TSPAN2 Products
Product Documents for TSPAN2 Antibody (822509) [DyLight 350]
Product Specific Notices for TSPAN2 Antibody (822509) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...